QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

NCT07463573 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

466

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)

Interventions

DRUG: QLC5508
DRUG: Investigator's Choice of Chemotherapy (docetaxel, paclitaxel, or Irinotecan Hydrochloride)

Sponsor

Qilu Pharmaceutical Co., Ltd.